Melanoma in Kauai, Hawaii, 1981-1990: The significance of in situ melanoma and the incidence trend

International Journal of Dermatology

Volumn 38, Issue 2, 1999, Pages 101-107

  Chuang, Tsu Yi ^a   Charles, Jonathan ^b   Reizner, George T ^b   Elpern, David J ^b   Farmer, Evan R ^b  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASIAN; BASAL CELL CARCINOMA; CANCER INCIDENCE; CARCINOMA IN SITU; CAUCASIAN; CHILD; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; HUMAN; INFANT; LIMB; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEWBORN; SQUAMOUS CELL CARCINOMA; TRUNK; TUMOR LOCALIZATION; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CROSS-CULTURAL COMPARISON; CULTURAL CHARACTERISTICS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HAWAII; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; JAPAN; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PHILIPPINES; SKIN; SKIN NEOPLASMS;

EID: 0033011941     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1999.00511.x     Document Type: Article

References (33)

1. Armstrong BK, Kricker A. Cutaneous melanoma. Cancer Surv 1994; 19-20: 219-240.
2. Boyle P, Maisonneuve P, Dore J-F. Epidemiology of malignant melanoma. Br Med Bull 1995; 51: 523-547.
3. Swerlick RA, Chen S. The melanoma epidemic. Is increased surveillance the solution or the problem? Arch Dermatol 1996; 132: 881-884.
4. Rees JL. The melanoma epidemic: reality and artefact warrants a reappraisal of the relation between histology and clinical behaviour. Br Med J 1996; 312: 137-138.
5. Giles GG, Armstrong BK, Burton RC, et al. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994. Br Med J 1996; 312: 1121-1125.
6. Roush GC, McKay L, Holford TRA. reversal in the long-term increase in deaths-attributable to malignant melanoma. Cancer 1992; 69: 1714-1720.
7. Farmer ER, Gonin R, Hanna MP. Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol 1996; 27: 528-531.
8. Reizner GT, Chuang T-Y, Elpern DJ, et al. Basal cell carcinoma in Kauai, Hawaii. The highest documented incidence in the United States. J Am Acad Dermatol 1993; 29: 184-189.
9. Ries LAG, Kosary CL, Hankey BF, et al. SEER Cancer Statistics Review, 1973-1994. Bethesda, MD: National Cancer Institute. NIH Publication No. 97-2789. pp. 305-318.
10. Elder DE. Skin cancer. Melanoma and other specific nonmelanoma skin cancers. Cancer 1995; 75: 245-256.
11. Scotto J, Pitcher H, Lee JAH. Indications of future decreasing trends in skin-melanoma mortality among whites in the United States. Int J Cancer 1991; 49: 490-497.
12. Burton RC, Coates MS, Hersey P, et al. An analysis of a melanoma epidemic. Int J Cancer 1993; 55: 765-770.
13. Newton JN, Redburn J. Incidence of melanoma in four English counties, 1989-92. Br Med J 1995; 310: 502-501.
14. Ko CB, Walton S, Keczkes K, et al. The emerging epidemic of skin cancer. Br J Dermatol 1994; 130: 269-272.
15. MacKie R, Hunter JAA, Aitchison TC, et al. Cutaneous malignant melanoma, Scotland, 1979-89. Lancet 1992; 339: 971-975.
16. Roder DM, Luke CG, McCaul KA, Esterman AJ. Trends in prognostic factors of melanoma in south Australia, 1981-92: Implications for health promotion. Med J Aust 1995; 162: 25-29.
17. English DR, Heenan PJ, Holman CDJ, et al. Melanoma in western Australia 1975-76 to 1980-81 Trend in demographic and pathological characteristics. Int J Cancer 1986; 37: 209-215.
18. Cooke K, McNoe B, Hursthouse M, Taylor R. Primary malignant melanoma of skin in four regions of New Zealand. NZ Med J 1992; 105: 303-306.
19. Popescu NA, Beard CM, Treacy PJ, et al. Cutaneous malignant melanoma in Rochester, Minnesota: trend in incidence and survivorship, 1950 through 1985 Mayo Clin Proc 1990; 65: 1293-1302.
20. Chuang T-Y, Popescu A, Su W-PD, Chute CG. Basal cell carcinoma. A population-based incidence study in Rochester, Minnesota. J Am Acad Dermatol 1990; 22: 413-417.
21. Chuang T-Y, Reizner GT, Elpern DJ, et al. Squamous cell carcinoma of the skin in Kauaiian Caucasians, Hawaii, U.S.A. Int J Dermatol 1995; 34: 393-397.
22. Chuang T-Y, Popescu A, Su W-PD, Chute CG. Squamous cell carcinoma. A population-based incidence study in Rochester, Minnesota. Arch Dermatol 1990; 126: 185-188.
23. Reizner GT, Chuang T-Y, Elpern DJ, et al. Bowen's disease (squamous cell carcinoma in situ) in Kauai, Hawaii. A population-based incidence report. J Am Acad Dermatol 1994; 31: 596-600.
24. Chute CG, Chuang T-Y, Bergstralh EJ, Su W-PD. The subsequent risk of internal cancer with Bowen's disease. A population-based study. J Am Med Assoc 1991; 266: 816-819.
25. Wassberg C, Thorn M, Yuen J, et al. Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden. Br J Cancer 1996; 73: 255-259.
26. Helm KF, Bittenbender S. Coexisting malignancies in patients with malignant melanoma. Arch Dermatol 1996; 132: 471-472.
27. Swerdlow AJ, Storm HH, Sasieni PD. Risks of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943-89. Int J Cancer 1995; 61: 773-779.
28. Armstrong BK, Kricker A. How much melanoma is caused by sun exposure? Melanoma Res 1993; 3: 395-401.
29. Elwood JM. Recent developments in melanoma epidemiology. 1993 Melanoma Res 1993; 3: 149-156.
30. Garbe C, Wiebelt H, Orfanos CE. Change of epidemiological characteristics of malignant melanoma during the years 1962-72 and 1983-86 in the Federal Republic of Germany. Dermatologica 1989; 178: 131-135.
31. Franceschi S, Cristofolini M. Cutaneous malignant melanoma: Epidemiologic consideration. Sem Surg Oncol 1992; 8: 345-352.
32. Hinds MW, Kolonel LN. Malignant melanoma of the skin in Hawaii, 1960-77. Cancer 1980; 45: 811-817.
33. Elwood JM. Epidemiology and control of melanoma in white populations and in Japan. J Invest Dermatol 1989; 29: S214-S221.